These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24554651)

  • 1. Autonomous parvoviruses neither stimulate nor are inhibited by the type I interferon response in human normal or cancer cells.
    Paglino JC; Andres W; van den Pol AN
    J Virol; 2014 May; 88(9):4932-42. PubMed ID: 24554651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.
    Paglino JC; Ozduman K; van den Pol AN
    J Virol; 2012 Jul; 86(13):7280-91. PubMed ID: 22553327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.
    Moerdyk-Schauwecker M; Shah NR; Murphy AM; Hastie E; Mukherjee P; Grdzelishvili VZ
    Virology; 2013 Feb; 436(1):221-34. PubMed ID: 23246628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inefficient type I interferon-mediated antiviral protection of primary mouse neurons is associated with the lack of apolipoprotein l9 expression.
    Kreit M; Paul S; Knoops L; De Cock A; Sorgeloos F; Michiels T
    J Virol; 2014 Apr; 88(7):3874-84. PubMed ID: 24453359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of an antiviral response in normal but not transformed mouse cells: a new determinant of minute virus of mice oncotropism.
    Grekova S; Zawatzky R; Hörlein R; Cziepluch C; Mincberg M; Davis C; Rommelaere J; Daeffler L
    J Virol; 2010 Jan; 84(1):516-31. PubMed ID: 19864388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells.
    Raykov Z; Grekova SP; Hörlein R; Leuchs B; Giese T; Giese NA; Rommelaere J; Zawatzky R; Daeffler L
    PLoS One; 2013; 8(1):e55086. PubMed ID: 23383065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.
    Westcott MM; Liu J; Rajani K; D'Agostino R; Lyles DS; Porosnicu M
    J Virol; 2015 Aug; 89(15):7944-54. PubMed ID: 25995245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells.
    Abschuetz A; Kehl T; Geibig R; Leuchs B; Rommelaere J; Régnier-Vigouroux A
    Cell Tissue Res; 2006 Sep; 325(3):423-36. PubMed ID: 16699801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic alpha interferon treatment increases the therapeutic index of oncolytic vesicular stomatitis virus virotherapy for advanced hepatocellular carcinoma in immune-competent rats.
    Shinozaki K; Ebert O; Suriawinata A; Thung SN; Woo SL
    J Virol; 2005 Nov; 79(21):13705-13. PubMed ID: 16227290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The parvoviral capsid controls an intracellular phase of infection essential for efficient killing of stepwise-transformed human fibroblasts.
    Paglino J; Tattersall P
    Virology; 2011 Jul; 416(1-2):32-41. PubMed ID: 21600623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses.
    Vollmers EM; Tattersall P
    Virology; 2013 Nov; 446(1-2):37-48. PubMed ID: 24074565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vectors based on autonomous parvoviruses: novel tools to treat cancer?
    Cornelis JJ; Salomé N; Dinsart C; Rommelaere J
    J Gene Med; 2004 Feb; 6 Suppl 1():S193-202. PubMed ID: 14978762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis.
    Ventoso I; Berlanga JJ; Almendral JM
    J Virol; 2010 May; 84(10):5043-51. PubMed ID: 20219905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
    Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
    J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer gene therapy through autonomous parvovirus--mediated gene transfer.
    Cornelis JJ; Lang SI; Stroh-Dege AY; Balboni G; Dinsart C; Rommelaere J
    Curr Gene Ther; 2004 Sep; 4(3):249-61. PubMed ID: 15384939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-Inducible Oligoadenylate Synthetase-Like Protein Acts as an Antiviral Effector against Classical Swine Fever Virus via the MDA5-Mediated Type I Interferon-Signaling Pathway.
    Li LF; Yu J; Zhang Y; Yang Q; Li Y; Zhang L; Wang J; Li S; Luo Y; Sun Y; Qiu HJ
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the differential response of two human fibroblast cell lines following Chikungunya virus infection.
    Thon-Hon VG; Denizot M; Li-Pat-Yuen G; Giry C; Jaffar-Bandjee MC; Gasque P
    Virol J; 2012 Sep; 9():213. PubMed ID: 22992396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection.
    Grekova SP; Raykov Z; Zawatzky R; Rommelaere J; Koch U
    Cancer Gene Ther; 2012 Jul; 19(7):468-75. PubMed ID: 22539062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parvovirus evades interferon-dependent viral control in primary mouse embryonic fibroblasts.
    Mattei LM; Cotmore SF; Tattersall P; Iwasaki A
    Virology; 2013 Jul; 442(1):20-7. PubMed ID: 23676303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer.
    Neulinger-Muñoz M; Schaack D; Grekova SP; Bauer AS; Giese T; Salg GA; Espinet E; Leuchs B; Heller A; Nüesch JPF; Schenk M; Volkmar M; Giese NA
    Viruses; 2021 May; 13(6):. PubMed ID: 34071585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.